These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33842320)

  • 1. Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma.
    Feng Y; Liu Y; Zhong M; Wang L
    Front Oncol; 2021; 11():618694. PubMed ID: 33842320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
    Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
    Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Risk Model Composed of Complete Blood Count,
    Wang L; Yuan L; Du X; Zhou K; Yang Y; Qin Q; Yang L; Xiang Y; Qu X; Liu H; Qin X; Liu C
    Front Oncol; 2022; 12():800786. PubMed ID: 35186740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
    Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
    Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy.
    Luo Q; Yang C; Fu C; Wu W; Wei Y; Zou L
    Front Oncol; 2021; 11():639644. PubMed ID: 33996552
    [No Abstract]   [Full Text] [Related]  

  • 6. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
    Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
    Front Oncol; 2021; 11():696147. PubMed ID: 34422649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
    Li Q; Yu L; Yang P; Hu Q
    Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
    Matsuda R; Maeoka R; Morimoto T; Nakazawa T; Morisaki Y; Yokoyama S; Kotsugi M; Takeshima Y; Yamada S; Nishimura F; Park YS; Nakagawa I
    J Neurooncol; 2024 Jul; 168(3):487-494. PubMed ID: 38658464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
    Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
    Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
    Front Immunol; 2021; 12():691364. PubMed ID: 34248983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
    Shi X; Li H; Xu Y; Nyalali AMK; Li F
    Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.
    Lo YT; Lim VY; Ng M; Tan YH; Chiang J; Chang EWY; Chan JY; Poon EYL; Somasundaram N; Bin Harunal Rashid MF; Tao M; Lim ST; Yang VS
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma.
    Jung J; Lee H; Yun T; Lee E; Moon H; Joo J; Park WS; Choi M; Lee JO; Lee JS; Eom HS
    Oncotarget; 2017 Sep; 8(43):74975-74986. PubMed ID: 29088839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
    Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
    Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis.
    Chen Z; Wang K; Lu H; Xue D; Fan M; Zhuang Q; Yin S; He X; Xu R
    Cancer Manag Res; 2019; 11():909-919. PubMed ID: 30697081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
    Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
    Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
    Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
    BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma.
    Cho U; Sung YE; Kim MS; Lee YS
    Biomedicines; 2022 May; 10(6):. PubMed ID: 35740290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.